Technology Partners
Technology Partners is a venture capital firm specialized in seed-, early-, and later-stage venture and private equity investments.
Business Model:
Revenue: $3.4M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Technology Partners Information
Geographic Data
Address: P O Box 1168
City: Novato
State: CA
Zip: 94948
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Technology Partners is a venture capital investor that focuses on cleantech and life science companies.
Contact Phone:
+14153329999
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 5/2007 | Tesla | Series D | 0 |
| 6/2009 | Transcend Medical | Series B | 35M |
| 2/2014 | Elcelyx Therapeutics | Series C | 0 |
| 10/2000 | APX | Series C | 0 |
| 4/2013 | Scioderm | Series A | 16M |
| 5/2002 | eNeura Therapeutics | Series A | 1M |
| 12/2009 | Revance Therapeutics | Series D | 0 |
| 4/2004 | Revance Therapeutics | Series B | 13M |
| 11/2009 | EmSense | Series C | 9M |
| 12/2012 | Tonix Pharmaceuticals | Venture Round | 1M |
| 6/2013 | ForSight Labs | Series B | 9.3M |
| 2/2002 | NightFire Software | Series D | 16.5M |
| 12/2012 | Tonix Pharmaceuticals | Post-IPO Equity | 1M |
| 9/2003 | Sensicore | Series B | 4.5M |
| 8/2007 | Leptos Biomedical | Series C | 20M |
| 7/2012 | Beamreach | Series C | 10.8M |
| 1/2003 | Iomai Corporation | Series C | 54M |
| 1/2012 | Transcend Medical | Series B | 16M |
| 8/2015 | Beamreach | Series D | 0 |
| 6/2013 | ForSight VISION5 | Series B | 9.3M |
| 11/2011 | Medley Health | Series A | 20M |
| 10/2012 | Akros Silicon | Venture Round | 8M |
| 3/2001 | Spinal Dynamics | Series B | 23M |
| 6/1997 | Spinal Dynamics | Series A | - |
| 1/2005 | ITM Software | Venture Round | 6M |
| 12/2002 | Datria Systems | Series C | 0 |
| 9/2003 | Storability Software | Series D | 7M |
| 7/2005 | CoalTek | Series A | 2.1M |
| 6/2011 | Transcend Medical | Series B | 51M |
| 3/2006 | BioTrove | Venture Round | 7M |
| 1/2016 | Benvenue Medical | Equity | 23M |
| 12/2007 | Imperium Renewables | Series B | 0 |
| 12/2006 | Accelergy | Series B | 25M |
| 5/2007 | TRIA Beauty | Series D | 0 |
| 8/2002 | PolyFuel | Series B | 15.6M |
| 4/2007 | Nfocus Neuromedical | Series B | 20.3M |
| 8/2008 | Abound Solar | Venture Round | 104M |
| 4/2014 | Transcend Medical | Series C | 0 |
| 10/2005 | eNeura Therapeutics | Series B | 5.1M |
| 1/2001 | Rinat Neuroscience | Series A | 17.5M |
| 10/2015 | Elcelyx Therapeutics | Series E | 0 |
| 4/2012 | Beamreach | Series C | 25M |
| 7/2008 | Beamreach | Series B | - |
| 8/2005 | Sensicore | Series C | 12M |
| 8/2012 | Elcelyx Therapeutics | Series B | 4M |
| 9/2014 | Kaiam | Venture Round | 35M |
| 6/2001 | Storability Software | Series B | 0 |
| 7/2002 | Storability Software | Series C | 10.8M |
| 6/2011 | Revance Therapeutics | Series D | 45M |
| 1/2005 | NeuroPace | Venture Round | 30M |
| 2/2011 | TRIA Beauty | Venture Round | 26.3M |
| 10/2012 | TRIA Beauty | Venture Round | 7.5M |
| 8/2000 | APX | Series C | 0 |
| 1/2006 | NanoGram | Venture Round | 0 |
| 8/2007 | ITM Software | Venture Round | 0 |
| 8/2003 | Rinat Neuroscience | Series B | 40M |
| 11/2003 | Saegis Pharmaceuticals | Series B | 30M |
| 3/2011 | Alta Devices | Private Equity Round | 72M |
| 7/2004 | PolyFuel | Series C | 18.4M |
| 8/1999 | HeartStent | Venture Round | 12.8M |
| 2/2000 | AllAdvantage | Venture Round | 100M |
| 9/2008 | PowerGenix | Funding Round | 30M |
| 4/2011 | Benvenue Medical | Series C | 35.5M |
| 4/2014 | ForSight VISION5 | Equity | 15M |
| 4/2014 | ForSight Labs | Series C | 15M |
| 8/2013 | Kaiam | Venture Round | 20M |
| 7/2014 | Beamreach | Series D | 0 |
| 8/2013 | Beamreach | Series C | 0 |
| 1/2004 | Accelergy | Series A | 12M |
| 9/2000 | Encirq Corporation | Venture Round | 37M |
| 11/2003 | ITM Software | Series B | 9M |
| 12/2006 | PowerGenix | Series C | 17M |
| 4/2000 | SkillsVillage | Series B | 0 |
| 6/2010 | Incline Therapeutics | Series A | 43M |
| 4/2000 | Eloan | Post-IPO Equity | 40M |
| 12/2007 | Revance Therapeutics | Series C | 0 |
| 4/2000 | Imagicast | Series C | 13M |
| 3/2008 | BrainCells | Series B | 30M |
| 5/2009 | Visiogen | Series D | 40M |
| 6/2006 | CoalTek | Series B | 5M |
| 6/2012 | Benvenue Medical | Series D | 25M |
| 6/2014 | Benvenue Medical | Series E | 40M |
| 8/2013 | CoalTek | Convertible Note | 750k |
| 1/2016 | Benvenue Medical | Series F | 0 |
| 10/2015 | Elcelyx Therapeutics | Series E | 0 |
| 8/2015 | Beamreach | Series D | 0 |
| 9/2014 | Kaiam | Venture Round | 0 |
| 7/2014 | Beamreach | Series D | 0 |
| 6/2014 | Benvenue Medical | Series E | 0 |
| 4/2014 | ForSight Labs | Series C | 0 |
| 4/2014 | ForSight VISION5 | Series C | 0 |
| 4/2014 | Transcend Medical | Series C | 0 |
| 2/2014 | Elcelyx Therapeutics | Series C | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
